Henderson Hospital
Henderson Hospital was paid $2.70M by Medicaid between Jan 2021 and Dec 2024, across 78 billing codes. Its largest line is 99285, emergency room visit (most serious) — 22% of everything it billed.
HENDERSON, NV 89074
Next to other Emergency Medical Services (Emergency Medicine) Physician providers in Nevada
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 23,975 | $434K | |
| 2022 | 32,150 | $804K | |
| 2023 | 33,379 | $850K | |
| 2024incomplete | 21,769 | $608K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 5,763 | 4,988 | $580K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 6,611 | 5,722 | $520K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 5,925 | 5,193 | $311K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 10% | 1,322 | 1,163 | $282K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.6% | 4,814 | 3,922 | $150K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.3% | 1,215 | 1,153 | $88K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.0% | 631 | 566 | $80K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 948 | 825 | $69K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.5% | 3,299 | 2,663 | $68K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.0% | 1,125 | 917 | $54K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 1,674 | 1,474 | $52K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.2% | 3,232 | 2,686 | $32K |
66 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,984 | $27K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,398 | $26K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 773 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,259 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,580 | $25K |
| 80053 | Comprehensive metabolic panel | <1% | 4,791 | $23K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,096 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,309 | $19K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 874 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,701 | $17K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 69 | $16K |
| 84484 | <1% | 3,774 | $16K | |
| 84702 | <1% | 2,387 | $15K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,770 | $14K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 158 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,613 | $10K |
| 83690 | <1% | 2,841 | $9K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 270 | $8K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,696 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,741 | $6K |
| 81001 | <1% | 3,960 | $6K | |
| 81025 | <1% | 1,687 | $5K | |
| 83605 | <1% | 1,149 | $5K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 75 | $5K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,623 | $4K |
| 85379 | <1% | 874 | $4K | |
| 83880 | <1% | 271 | $4K | |
| 73630 | <1% | 258 | $4K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 97 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 495 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 153 | $3K |
| 96376 | <1% | 289 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,744 | $2K |
| 93971 | <1% | 43 | $2K | |
| 85730 | <1% | 689 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,659 | $2K |
| 73564 | <1% | 82 | $1K | |
| 73130 | <1% | 92 | $1K | |
| 85610 | <1% | 803 | $1K | |
| 81003 | <1% | 1,182 | $1K | |
| 73610 | <1% | 68 | $1K | |
| 87077 | <1% | 268 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 80 | $916.07 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,874 | $908.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 613 | $870.08 |
| 87186 | <1% | 216 | $779.14 | |
| 83735 | <1% | 207 | $595.59 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 40 | $575.28 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 40 | $575.28 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 547 | $388.53 |
| 87040 | <1% | 87 | $354.60 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 365 | $350.70 |
| 80076 | <1% | 76 | $293.12 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 358 | $283.73 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 77 | $233.12 |
| 73030 | <1% | 12 | $206.92 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15 | $202.64 |
| 82550 | <1% | 30 | $85.62 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 216 | $46.54 |
| 85027 | <1% | 14 | $40.13 | |
| 82248 | <1% | 14 | $24.25 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 34 | $21.70 |
| 82962 | <1% | 15 | $17.34 | |
| 0353U | 0% | 47 | $0.00 | |
| 90715 | 0% | 15 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.